Altogether, circulating elevated lncRNA GAS5 levels correlated with the progression of liver fibrosis prior to the development of cirrhosis can be used to serve as a valid non-invasive marker in patients with NAFLD and CHB with liver fibrosis (Han et al., 2020). Here, GAS5 is linked to Hepatic fibrosis.